Can Zyprexa (olanzapine) 10mg be scheduled as 5mg twice a day if causing insomnia at night?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Splitting Zyprexa (Olanzapine) Dosing for Insomnia

No, Zyprexa (olanzapine) 10mg should not be split into 5mg twice daily for insomnia—this is not an appropriate use of this medication, and the evidence does not support olanzapine for treating insomnia at any dosing schedule. 1

Why Olanzapine Should Not Be Used for Insomnia

Lack of Evidence-Based Support

  • Olanzapine is FDA-approved as an antipsychotic for schizophrenia and bipolar disorder, not for insomnia. 1
  • The recommended starting dosage is 5-10 mg orally once daily for its approved psychiatric indications, not for sleep disorders. 1
  • While one small open trial with only 9 patients suggested possible benefit for sleep disorders, this is insufficient evidence to support its use, and the authors themselves acknowledged the population was too small to prove effectiveness. 2

Significant Safety Concerns

  • Olanzapine causes insomnia as a common adverse effect (along with somnolence, agitation, and headache), making it paradoxical to use for treating insomnia. 1
  • Serious adverse events have been reported even with off-label low-dose use, including hyperventilation with respiratory alkalosis requiring ICU admission and mechanical ventilation in elderly postoperative patients. 3
  • The drug is associated with metabolic adverse events including weight gain, diabetes, obesity, and hyperlipidemia. 4
  • Hepatic transaminase elevations occur with olanzapine use. 1

Evidence-Based Alternatives for Insomnia

First-Line Pharmacologic Options

For sleep onset insomnia:

  • Zolpidem 5 mg (for women and elderly) or 10 mg (for men) taken immediately before bedtime reduces sleep latency by 10-15 minutes and increases total sleep time by 23-29 minutes. 5
  • Zaleplon 10 mg for non-elderly adults (5 mg for elderly ≥65 years) specifically targets sleep onset, though evidence is weaker than for zolpidem. 6

For sleep maintenance insomnia:

  • Zolpidem is effective for both sleep onset and maintenance, reducing wake after sleep onset by 25 minutes with extended-release formulations. 5
  • Zaleplon has minimal effects on sleep maintenance and should not be used for this indication. 6

Dosing Strategy to Minimize Side Effects

  • Consider as-needed dosing (3-5 nights per week) rather than nightly use to reduce tolerance risk and total drug exposure while maintaining efficacy. 5
  • Take zolpidem on an empty stomach immediately before bedtime to maximize effectiveness and minimize next-day impairment. 5
  • Avoid combining with alcohol or other CNS depressants. 5

Critical Pitfalls to Avoid

  • Never use atypical antipsychotics like olanzapine or quetiapine off-label for insomnia—the safety concerns outweigh any potential benefits, particularly regarding metabolic effects and serious adverse events. 3, 4
  • Splitting doses of sedating medications throughout the day defeats the purpose of treating nighttime insomnia and increases daytime sedation risk.
  • The pharmacokinetics of olanzapine (well absorbed from GI tract with no food effect) do not support twice-daily dosing for any indication. 1

References

Research

Olanzapine: a serotonin-dopamine-receptor antagonist for antipsychotic therapy.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998

Research

Safety of low doses of quetiapine when used for insomnia.

The Annals of pharmacotherapy, 2012

Guideline

Zolpidem Dosage and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Zaleplon Dosing and Efficacy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.